Profound Medical Corp. (PROF)
NCM – Real vaqt narxi. Valyuta: USD
7.14
-0.11 (-1.52%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
7.14
-0.11 (-1.52%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Profound Medical Corp. tijorat bosqichidagi tibbiy qurilmalar kompaniyasi bo'lib, u tasvir nazorati ostida kasal to'qimalarni yo'q qilish uchun sun'iy intellektga asoslangan, MRT nazoratidagi, kesmasdan davolash tizimlarini ishlab chiqadi va sotadi. Kompaniyaning asosiy mahsuloti TULSA-PRO tizimi magnit-rezonans tomografiyasi (MRT), robotlashtirilgan uretradan tashqari supurish harakati/termal ultratovush va yopiq-pastadir harorati nazoratini birlashtirib, butun bez yoki shifokor tomonidan belgilangan malign yoki yaxshi sifatli prostata to'qimalari hududini yo'q qiladi. Shuningdek, u bachadon miomasi, adenomioz to'qimalari, suyak metastazlarining og'riqni yengillashtiruvchi davolash, osteoid osteoma va yaxshi sifatli o'smalarni boshqarish uchun real vaqt rejimida MRT va termometriyani birlashtirgan Sonalleve-ni taqdim etadi. Kompaniya Kanada, Germaniya, AQSh, Xitoy va Finlandiyada faoliyat yuritadi. Profound Medical Corp. shtab-kvartirasi Missisauga, Kanadada joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Arun Swarup Menawat MBA, Ph.D. | Chairman of the Board & CEO |
| Dr. Mathieu Burtnyk Ph.D. | President |
| Mr. Levant Tinaz | Software Developer |
| Mr. Matthew Sobczyk C.A., CPA | Assistant Corporate Controller |
| Mr. Rashed Dewan | Chief Financial Officer |
| Mr. Stephen Kilmer | Investor Relations |
| Mr. Thomas Tamberrino MBA | Chief Commercial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-07 | 10-Q | prof-20260331x10q.htm |
| 2026-04-16 | 8-K | f8k_041626.htm |
| 2026-04-14 | 8-K | f8k_041426.htm |
| 2026-04-01 | 8-K | f8k_040126.htm |
| 2026-03-27 | 8-K | f8k_032726.htm |
| 2026-03-13 | 8-K | f8k_031326.htm |
| 2026-03-10 | 8-K | tm268477d1_8k.htm |
| 2026-03-09 | 8-K | f8k_030926.htm |
| 2026-03-05 | 8-K | f8k_030526.htm |
| 2026-02-12 | 8-K | f8k_021226.htm |